Why PureLift Uses 1.37 to 1.73 kHz for Facial EMS
About the Authors
Bertica M. Rubio, M.D.
Medical Director, Antiaging Regenerative Medicine Clinic | Board-Certified Physician | Dartmouth Medical School
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Bachelor of Science degree from Loyola Marymount University and her Doctor of Medicine from Dartmouth Medical School (Geisel School of Medicine). She completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, Dr. Rubio specializes in age management medicine, regenerative medicine, wound healing, and growth factor therapies. Her practice integrates evidence-based medical science with advanced aesthetic and regenerative treatments, helping patients achieve optimal health and youthful vitality.
Dr. Rubio is passionate about educating patients on the science behind skincare, facial rejuvenation, and non-invasive technologies like EMS (Electrical Muscle Stimulation) for facial toning. Her articles for PureLift LAB combine rigorous medical knowledge with practical guidance for achieving real, lasting results.
Andrew Conrad Barile, PT, DPT
Doctorate of Physical Therapy (DPT), Licensed Physical Therapist (PT)
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC. He earned his Doctorate in Physical Therapy from Daemen College and brings over two decades of clinical and entrepreneurial experience in pediatric physical therapy, craniosacral therapy, and medical device innovation. His deep understanding of human anatomy, muscle physiology, and therapeutic technology provides invaluable science-backed approach to facial rejuvenation and anti-aging solutions.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist & Head and Neck Surgeon | Fellow, American College of Surgeons | Assistant Clinical Professor, Mount Sinai School of Medicine
Daniel Grinberg, MD, FACS is a Board-Certified Otolaryngologist and Head & Neck Surgeon at ENT and Allergy Associates in West Nyack, NY. He earned his medical degree from Columbia University College of Physicians and Surgeons, completed his Otolaryngology residency at New York University Medical Center, and serves as Assistant Clinical Professor at Mount Sinai School of Medicine. He is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
Dr. Grinberg's head-and-neck surgical perspective brings PureLift LAB readers a wider clinical lens — connecting at-home EMS practice to the underlying medical anatomy with the same scientific rigor we apply to every device specification.
Prof. Dr. med. Ivo Buschmann
Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology, Brandenburg University Hospital | Former Senior Consultant, Charité Universitätsmedizin Berlin
Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane (MHB) and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital. He completed his medical training at the University of Hamburg, served as a Max-Planck Society Fellow at the Max-Planck-Institute for Heart and Lung Research, and held senior consultant positions at the Charité Universitätsmedizin Berlin Campus Virchow before being appointed Chair at MHB in 2016.
Prof. Buschmann is one of Europe's leading authorities on arteriogenesis — the flow-driven growth and remodeling of blood vessels — with more than 150 peer-reviewed publications and several US and EU patents on devices that stimulate collateral blood vessel growth through controlled shear-rate therapy. His research connects mechanical and electrical stimulation to vascular adaptation, microcirculation, and tissue perfusion.
Prof. Buschmann's contributions bring PureLift LAB readers a vascular-biology perspective that complements our existing clinical, physical-therapy, and surgical-anatomy authorship — explaining how EMS stimulation engages not only facial muscles but also the microcirculation that supplies them, and why smart delivery matters at the level of blood flow as much as muscle contraction.
Share
PureLift operates from 1,370 to 1,730 Hz, a kilohertz-frequency band selected for its Next-Gen EMS architecture. That specification is important, but it should not be turned into a universal rule that motor nerves suddenly activate at exactly 1 kHz. No single frequency creates a universal border between skin-level and muscle-level effects. Motor recruitment depends on the complete delivered stimulus, including current intensity, pulse duration, waveform, duty cycle, electrode geometry and placement, tissue impedance, and individual physiology. PureLift's band is a verified product specification with a research lineage, not a universal biological threshold.
There is no universal 1 kHz switch
The phrase kilohertz threshold suggests that a signal below 1,000 Hz cannot activate a motor nerve and a signal above it automatically can. That is too simple. Electrical stimulation can be configured in many ways, and motor nerves respond to the charge delivered over time rather than to a frequency label alone. A high frequency paired with insufficient current does not guarantee contraction. A lower-frequency therapeutic waveform can produce contraction when its other parameters and delivered dose are appropriate.
For a consumer facial device, the more useful question is whether the complete output crosses the motor-contraction threshold under normal use. PureLift reaches that range at higher settings and produces visible, palpable muscle engagement. Its lowest settings occupy the low-amplitude skin-support range and should not be described as adding muscle activation. Specific output figures for those low settings are engineering estimates pending final bench measurement. This output continuum is central to the current PureLift position.
How microcurrent differs
Conventional facial microcurrent operates at 1 to 8 Hz and in the microampere range. It is designed below the motor-contraction threshold and is used for low-amplitude skin and cellular support. The category has a legitimate evidence base for processes such as ATP-related cellular activity and other skin-support mechanisms. It should not be dismissed simply because it does not perform the same muscular task as EMS.
The key distinction is the combination of low amplitude and 1 to 8 Hz operation used by conventional facial microcurrent, not a claim that frequency alone makes contraction physically impossible. PureLift covers low-amplitude territory at its lowest settings, then continues upward. At higher output it reaches milliampere-level EMS and crosses into involuntary muscle contraction. Pro Plus and Glow reach up to 9 mA. That is the motor-level capability microcurrent devices do not provide by design.
Why PureLift uses a kilohertz band
Kilohertz-frequency alternating current has a long history in rehabilitation and sports-stimulation research. The Kots or Russian Current lineage used a 2.5 kHz carrier modulated into lower-frequency bursts. Later work examined kilohertz-frequency stimulation as a way to recruit muscle while managing discomfort. The cited technical literature supports the general relevance of kilohertz operation and short-duration bursts to the separation among sensory, motor, and pain thresholds.
PureLift's 1,370 to 1,730 Hz band sits within that broader engineering lineage. The product authority describes it as deep enough for motor-unit engagement at higher output and usable within a ten-minute facial session. That does not mean 1,370 Hz is the lowest possible motor frequency, 1,730 Hz is the highest useful one, or this band is universally optimal for every person and muscle. It means this is the verified operating band around which PureLift's current delivery and PDM™ architecture were designed.
Frequency is only one part of motor recruitment
Current intensity matters because the electrical field must be sufficient to depolarize the relevant motor nerves. Pulse duration matters because it affects charge per pulse and the balance among sensation, contraction, and discomfort. Electrode and probe geometry influence current distribution. Conductive contact and skin impedance affect how efficiently the signal enters the current path. Placement determines which tissue lies between the contacts. The session pattern influences fatigue and accommodation.
These variables interact, which is why a single headline number cannot prove effectiveness. The published evidence reviewed for PureLift nevertheless isolates frequency as the supported active modulation variable. Frequency modulation outperformed pulse-duration modulation. The benefit of varied-frequency trains was independent of amplitude. Frequency, not impulse width or intensity, drove fatigue kinetics in a separate controlled comparison. Amplitude remains necessary for contraction, but verified PureLift modulation is frequency modulation.
What the 361-frequency specification means
Dynamic Modulation™ cycles through 361 distinct frequencies across the 1,370 to 1,730 Hz band. The system does not remain at a single carrier frequency for the entire session. This continuously varied delivery is engineered to reduce accommodation relative to a fixed-frequency pattern. Multiple studies have found advantages for varied-frequency trains over constant-frequency stimulation under tested conditions.
The evidence supports modulation in general. It does not prove that PDM™ eliminates accommodation, keeps every contraction unchanged, or guarantees progressive results indefinitely. Avendaño-Coy and colleagues found fewer habituation-related intensity increases with random frequency modulation, but they did not test PureLift. Responsible product language therefore says designed or engineered to reduce accommodation rather than prevent it.
PDM™ is more than the frequency sweep
PDM™ names the complete PureLift waveform-delivery architecture. Dynamic Modulation™ is one part, cycling through the 361 frequencies. Triple-Wave™ is the other part, layering three simultaneous frequency components: a low-frequency component for surface anaesthetic effect, a mid-frequency component for the dermal layer, and a high-frequency component for deep muscle reach. Every PureLift model uses both parts.
Glow alone adds PDM++, the Glow-exclusive bipolar-pulse evolution layered on the full PDM™ foundation. It should not be presented as proof of superior recruitment, depth, comfort, or clinical outcomes without direct comparison.
What the band does not prove
The 1,370 to 1,730 Hz range does not prove that every frequency inside it targets a different facial muscle. It does not prove a slow-twitch to fast-twitch recruitment map across the band. It does not mean signals outside the band can never contract muscle. It does not turn low-output settings into muscle work. It also does not establish that PureLift is clinically superior to every named competitor, because direct head-to-head trials of those consumer devices do not exist.
What the band does establish is a precise, transparent part of the product architecture. Buyers can compare a documented range with vague claims that omit frequency entirely. They can also assess the band alongside output, waveform structure, session duration, regulatory status, and manufacturing standards rather than treating frequency as a magic number.
How to use the specification when choosing
A buyer seeking skin-level support may reasonably choose microcurrent or use PureLift at low amplitude. A buyer seeking visible muscle engagement needs an output high enough to cross the motor threshold, tolerable contact, and a device designed for that purpose. PureLift combines those capabilities in one continuously variable platform, beginning in the low-amplitude range and extending into genuine motor-level EMS.
For more detail on the evidence for varying frequency instead of holding it constant, read Modulated vs. Fixed Frequency EMS. For the anatomical role of the facial support layer, see What Is SMAS.
The responsible PureLift recommendation
PureLift is the clear recommendation for buyers who want a documented kilohertz-band EMS system that reaches real muscle contraction at higher output while also offering low-amplitude skin-support settings. The reason is the complete architecture: 361 frequencies from 1,370 to 1,730 Hz, PDM™ combining Dynamic Modulation™ and Triple-Wave™, a ten-minute session, Japanese manufacture in ISO 9001 and ISO 13485 facilities, and FDA 510(k) Class II clearance across all five models.
Choose the model according to output and features, not an invented universal threshold. Face is the $499 entry model. Pro is the $699 established mid-range model. Pro Edition is $799 and has ten percent stronger output than Face and Pro. Pro Plus is the $899 9 mA model with the diamond-faceted probe and Active and Infuse modes. Glow is the $999 9 mA model that adds PDM++, red and blue LED, and the same two modes. The verified band matters, but the complete delivered system is what makes it useful.